{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:45:32Z","timestamp":1790239532845,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Surgical Infection Society","award":["Basic\/Translational Research Training Fellowship Grant"],"award-info":[{"award-number":["Basic\/Translational Research Training Fellowship Grant"]}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01 GM082852"],"award-info":[{"award-number":["R01 GM082852"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01 GM116929"],"award-info":[{"award-number":["R01 GM116929"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM119519"],"award-info":[{"award-number":["R35GM119519"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM008516"],"award-info":[{"award-number":["T32GM008516"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Clinical and biologic phenotypes of sepsis are proposed in human studies, yet it is unknown whether prognostic or drug response phenotypes are present in animal models of sepsis. Using a biotelemetry-enhanced, murine cecal ligation and puncture (CLP) model, we determined phenotypes of polymicrobial sepsis prior to physiologic deterioration, and the association between phenotypes and outcome in a randomized trial of prompt or delayed antibiotics and fluids.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We performed a secondary analysis of male C57BL\/6J mice in two observational cohorts and two randomized, laboratory animal experimental trials. In cohort 1, mice (<jats:italic>n<\/jats:italic>\u2009=\u2009118) underwent biotelemetry-enhanced CLP, and we applied latent class mixed models to determine optimal number of phenotypes using clinical data collected between injury and physiologic deterioration. In cohort 2 (<jats:italic>N<\/jats:italic>\u2009=\u200973 mice), inflammatory cytokines measured at 24\u2009h after deterioration were explored by phenotype. In a subset of 46 mice enrolled in two trials from cohort 1, we tested the association of phenotypes with the response to immediate (0\u2009h) vs. delayed (2 to 4\u2009h) antibiotics or fluids initiated after physiologic deterioration.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Latent class mixture modeling derived a two-class model in cohort 1. Class 2 (<jats:italic>N<\/jats:italic>\u2009=\u200997) demonstrated a shorter time to deterioration (mean SD 7.3 (0.9) vs. 9.7 (3.2)\u00a0h, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and lower heart rate at 7\u2009h after injury (mean (SD) 564 (55) vs. 626 (35) beats per minute, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Overall mortality was similar between phenotypes (<jats:italic>p<\/jats:italic>\u2009=\u20090.75). In cohort 2 used for biomarker measurement, class 2 mice had greater plasma concentrations of IL6 and IL10 at 24\u2009h after CLP (<jats:italic>p<\/jats:italic>\u2009=\u20090.05). In pilot randomized trials, the effects of sepsis treatment (immediate vs. delayed antibiotics) differed by phenotype (<jats:italic>p<\/jats:italic>\u2009=\u20090.03), with immediate treatment associated with greater survival in class 2 mice only. Similar differential treatment effect by class was observed in the trial of immediate vs. delayed fluids (<jats:italic>p<\/jats:italic>\u2009=\u20090.02).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>We identified two sepsis phenotypes in a murine cecal ligation and puncture model, one of which is characterized by faster deterioration and more severe inflammation. Response to treatment in a randomized trial of immediate versus delayed antibiotics and fluids differed on the basis of phenotype.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13054-019-2655-7","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T18:03:12Z","timestamp":1574964192000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Murine sepsis phenotypes and differential treatment effects in a randomized trial of prompt antibiotics and fluids"],"prefix":"10.1186","volume":"23","author":[{"given":"Christopher W.","family":"Seymour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha J.","family":"Kerti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Brant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Griepentrog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek C.","family":"Angus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Chou H.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Rosengart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,28]]},"reference":[{"issue":"8","key":"2655_CR1","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.0288","volume":"315","author":"CW Seymour","year":"2016","unstructured":"Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of Clinical Criteria for Sepsis: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):762\u201374.","journal-title":"JAMA."},{"issue":"14","key":"2655_CR2","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/jama.2018.12179","volume":"320","author":"Michael Klompas","year":"2018","unstructured":"Klompas M, Calandra T, Singer M. Antibiotics for Sepsis-Finding the Equilibrium. JAMA. 2018;320(14):1433\u20134. https:\/\/doi.org\/10.1001\/jama.2018.12179.","journal-title":"JAMA"},{"issue":"11","key":"2655_CR3","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1001\/jama.2013.2194","volume":"309","author":"SM Opal","year":"2013","unstructured":"Opal SM, Laterre PF, Francois B, et al. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA. 2013;309(11):1154\u201362.","journal-title":"JAMA"},{"key":"2655_CR4","unstructured":"Investigators P. Early, goal-directed therapy for septic shock - a patient-level meta-analysis. N Engl J Med. 2017."},{"issue":"9","key":"2655_CR5","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1164\/rccm.201411-2125CP","volume":"192","author":"TJ Iwashyna","year":"2015","unstructured":"Iwashyna TJ, Burke JF, Sussman JB, Prescott HC, Hayward RA, Angus DC. Implications of heterogeneity of treatment effect for reporting and analysis of randomized trials in critical care. AmJ Respir Crit Care Med. 2015;192(9):1045\u201351.","journal-title":"AmJ Respir Crit Care Med"},{"issue":"20","key":"2655_CR6","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"CW Seymour","year":"2019","unstructured":"Seymour CW, Kennedy JN, Wang S, et al. Derivation, validation and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019;321(20):2003\u201317.","journal-title":"JAMA"},{"issue":"6","key":"2655_CR7","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/CCM.0000000000003084","volume":"46","author":"TE Sweeney","year":"2018","unstructured":"Sweeney TE, Azad TD, Donato M, et al. Unsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clusters. Crit Care Med. 2018;46(6):915\u201325.","journal-title":"Crit Care Med"},{"issue":"12","key":"2655_CR8","doi-asserted-by":"publisher","first-page":"e1289","DOI":"10.1097\/CCM.0000000000002733","volume":"45","author":"Hector R. Wong","year":"2017","unstructured":"Wong HR, Sweeney TE, Hart KW, Khatri P, Lindsell CJ. Pediatric sepsis endotypes among adults with sepsis. Crit Care Med. 201745(12):e1289\u2013e1291. https:\/\/doi.org\/10.1097\/CCM.0000000000002733.","journal-title":"Critical Care Medicine"},{"issue":"10","key":"2655_CR9","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","volume":"5","author":"BP Scicluna","year":"2017","unstructured":"Scicluna BP, van Vught LA, Zwinderman AH, et al. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. Lancet Respir Med. 2017;5(10):816\u201326.","journal-title":"Lancet Respir Med"},{"issue":"12","key":"2655_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001916","volume":"12","author":"L McHugh","year":"2015","unstructured":"McHugh L, Seldon TA, Brandon RA, et al. A molecular host response assay to discriminate between sepsis and infection-negative systemic inflammation in critically ill patients: discovery and validation in independent cohorts. PLoS Med. 2015;12(12):e1001916.","journal-title":"PLoS Med"},{"issue":"11","key":"2655_CR11","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1097\/CCM.0b013e3182257675","volume":"39","author":"HR Wong","year":"2011","unstructured":"Wong HR, Cvijanovich NZ, Allen GL, et al. Validation of a gene expression-based subclassification strategy for pediatric septic shock. Crit Care Med. 2011;39(11):2511\u20137.","journal-title":"Crit Care Med"},{"issue":"5","key":"2655_CR12","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1097\/CCM.0b013e31819df06b","volume":"37","author":"MF Osuchowski","year":"2009","unstructured":"Osuchowski MF, Connett J, Welch K, Granger J, Remick DG. Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis. Crit Care Med. 2009;37(5):1567\u201373.","journal-title":"Crit Care Med"},{"key":"2655_CR13","doi-asserted-by":"publisher","unstructured":"Kim J, Arnaout L, Remick DG. Hydrocortisone, ascorbic acid and thiamine (HAT) theray decreases oxidative stress, improves cardiovascular function and improves survival in murine sepsis. Shock. 2019. https:\/\/doi.org\/10.1097\/SHK0000000000001385.","DOI":"10.1097\/SHK0000000000001385"},{"key":"2655_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/1756-0500-7-233","volume":"7","author":"B Shrum","year":"2014","unstructured":"Shrum B, Anantha RV, Xu SX, et al. A robust scoring system to evaluate sepsis severity in an animal model. BMC Res Notes. 2014;7:233.","journal-title":"BMC Res Notes"},{"issue":"3","key":"2655_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1164\/rccm.201603-0645OC","volume":"195","author":"KR Famous","year":"2017","unstructured":"Famous KR, Delucchi K, Ware LB, et al. Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med. 2017;195(3):331\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"2655_CR16","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.1097\/CCM.0000000000003004","volume":"46","author":"AJ Lewis","year":"2018","unstructured":"Lewis AJ, Griepentrog JE, Zhang X, Angus DC, Seymour CW, Rosengart MR. Prompt administration of antibiotics and fluids in the treatment of sepsis: a murine trial. Crit Care Med. 2018;46(5):e426\u201334.","journal-title":"Crit Care Med"},{"issue":"6","key":"2655_CR17","doi-asserted-by":"publisher","first-page":"e420","DOI":"10.1097\/CCM.0000000000001615","volume":"44","author":"AJ Lewis","year":"2016","unstructured":"Lewis AJ, Yuan D, Zhang X, Angus DC, Rosengart MR, Seymour CW. Use of biotelemetry to define physiology-based deterioration thresholds in a murine cecal ligation and puncture model of Sepsis. Crit Care Med. 2016;44(6):e420\u201331.","journal-title":"Crit Care Med"},{"issue":"1","key":"2655_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/SHK.0b013e3182356f3e","volume":"37","author":"R Moitra","year":"2011","unstructured":"Moitra R, Beal DR, Belikoff BG, Remick DG. Presence of pre-existing antibodies mediate survival in sepsis. Shock. 2011;37(1):56\u201362.","journal-title":"Shock."},{"key":"2655_CR19","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1097\/01.CCM.0000282078.80187.7F","volume":"35","author":"C Kiank","year":"2007","unstructured":"Kiank C, et al. Seasonal variations in inflammatory responses to sepsis and stress in mice. Crit Care Med. 2007;35:2352\u20138.","journal-title":"Crit Care Med"},{"key":"2655_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/01.shk.0000191414.94461.7e","volume":"24","author":"WJ Hubbard","year":"2005","unstructured":"Hubbard WJ, Choudhry M, Schwacha MG, et al. Cecal ligation and puncture. Shock. 2005;24:52\u20137.","journal-title":"Shock."},{"issue":"7","key":"2655_CR21","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707\u201310.","journal-title":"Intensive Care Med"},{"issue":"6","key":"2655_CR22","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/SHK.0b013e3182939831","volume":"39","author":"O Huet","year":"2013","unstructured":"Huet O, Ramsey D, Miljavec S, et al. Ensuring animal welfare while meeting scientific aims using a murine pneumonia model of septic shock. Shock. 2013;39(6):488\u201394.","journal-title":"Shock."},{"issue":"6","key":"2655_CR23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/00024382-200206000-00004","volume":"17","author":"DG Remick","year":"2002","unstructured":"Remick DG, Bolgos GR, Siddiqui J, Shin J, Nemzek JA. Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock. 2002;17(6):463\u20137.","journal-title":"Shock."},{"issue":"8","key":"2655_CR24","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jama.2016.0289","volume":"315","author":"M Shankar-Hari","year":"2016","unstructured":"Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):775\u201387.","journal-title":"JAMA."},{"issue":"10","key":"2655_CR25","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1136\/thoraxjnl-2016-209719","volume":"72","author":"LD Bos","year":"2017","unstructured":"Bos LD, Schouten LR, van Vught LA, et al. Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis. Thorax. 2017;72(10):876\u201383.","journal-title":"Thorax."},{"issue":"7","key":"2655_CR26","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1164\/rccm.201609-1848OC","volume":"196","author":"VX Liu","year":"2017","unstructured":"Liu VX, Fielding-Singh V, Greene JD, et al. The timing of early antibiotics and hospital mortality in Sepsis. Am J Respir Crit Care Med. 2017;196(7):856\u201363.","journal-title":"Am J Respir Crit Care Med"},{"issue":"23","key":"2655_CR27","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","volume":"376","author":"CW Seymour","year":"2017","unstructured":"Seymour CW, Gesten F, Prescott HC, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017;376(23):2235\u201344.","journal-title":"N Engl J Med"},{"issue":"11","key":"2655_CR28","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1097\/CCM.0000000000000541","volume":"42","author":"B Andrews","year":"2014","unstructured":"Andrews B, Muchemwa L, Kelly P, Lakhi S, Heimburger DC, Bernard GR. Simplified severe sepsis protocol: a randomized controlled trial of modified early goal-directed therapy in Zambia. Crit Care Med. 2014;42(11):2315\u201324.","journal-title":"Crit Care Med"},{"issue":"26","key":"2655_CR29","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1056\/NEJMoa1101549","volume":"364","author":"K Maitland","year":"2011","unstructured":"Maitland K, Kiguli S, Opoka RO, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011;364(26):2483\u201395.","journal-title":"N Engl J Med"},{"key":"2655_CR30","doi-asserted-by":"publisher","unstructured":"de Tymowski C, Correia MDT, Monteiro RC, Montravers P, Ben Mkaddem S. Bacterial proliferation may be the key component of sepsis mortality. Infect Immun. 2018; 86Le00948\u201317. doi:https:\/\/doi.org\/10.1128\/IAI.00948-17.","DOI":"10.1128\/IAI.00948-17"},{"issue":"2","key":"2655_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1145\/304181.304187","volume":"28","author":"M Ankerst","year":"1999","unstructured":"Ankerst M. OPTICS: Ordering points to identify the clustering structure. SIGMOD. 1999;28(2):49\u201360.","journal-title":"SIGMOD"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-019-2655-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-019-2655-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-019-2655-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:39:15Z","timestamp":1606437555000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-019-2655-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,28]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2655"],"URL":"https:\/\/doi.org\/10.1186\/s13054-019-2655-7","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,28]]},"assertion":[{"value":"12 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments were approved by the University of Pittsburgh Institutional Animal Care and Use Committee (PRO13021581) in accordance with guidelines established by the National Institutes of Health.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"384"}}